We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

235 hedge funds and large institutions have $3.22B invested in Array Biopharma Inc in 2018 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 83 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

230% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 20

46% more call options, than puts

Call options by funds: $27.3M | Put options by funds: $18.7M

34% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 62

26% more capital invested

Capital invested by funds: $2.56B → $3.22B (+$660M)

23% more funds holding

Funds holding: 191 → 235 (+44)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
235
Holders Change
+44
Holders Change %
+23.04%
% of All Funds
5.39%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
66
Increased
83
Reduced
62
Closed
20
Calls
$27.3M
Puts
$18.7M
Net Calls
+$8.62M
Net Calls Change
-$12.9M

Top Buyers

1
FCM
Farallon Capital Management
California
+$49.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39.5M
3
American Century Companies
American Century Companies
Missouri
+$25.4M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.8M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$19.6M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$84.3M
2
BI
BVF Inc
California
-$58M
3
ACA
Avoro Capital Advisors
New York
-$56.8M
4
O
OrbiMed
New York
-$43.6M
5
Morgan Stanley
Morgan Stanley
New York
-$33.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
JFA
226
JNBA Financial Advisors
Minnesota
$8K – – –
SWM
227
SeaCrest Wealth Management
New York
$5K – – –
KF
228
Krilogy Financial
Missouri
$5K +$1.6K +100 +50%
PS
229
Portfolio Solutions
Michigan
$4K -$1.76K -110 -34%
BWA
230
BDO Wealth Advisors
Florida
$3K – – –
ARMC
231
American Research & Management Company
Massachusetts
$2K – – –
WTB
232
Washington Trust Bank
Washington
$2K +$1.6K +100 New
TDC
233
Thompson Davis & Co
Virginia
$2K +$2K +125 New
FMA
234
FNY Managed Accounts
New York
$2K +$2.79K +174 New
Susquehanna International Group
235
Susquehanna International Group
Pennsylvania
– -$8.34M -520,780 Closed
GTC
236
Ghost Tree Capital
New York
– -$6.4M -500,000 Closed
PC
237
Polar Capital
United Kingdom
– -$3.2M -250,000 Closed
Parallax Volatility Advisers
238
Parallax Volatility Advisers
California
– -$1.82M -142,019 Closed
LCM
239
Landscape Capital Management
New Jersey
– -$1.02M -79,803 Closed
AAMU
240
Amundi Asset Management US
Massachusetts
– -$702K -54,900 Closed
SEC
241
Seven Eight Capital
New York
– -$620K -48,400 Closed
Wolverine Trading
242
Wolverine Trading
Illinois
– -$525K -32,801 Closed
JG
243
Jefferies Group
New York
– -$185K -14,475 Closed
KM
244
Kalos Management
Georgia
– -$143K -11,177 Closed
QT
245
Quantbot Technologies
New York
– -$126K -9,879 Closed
Pacer Advisors
246
Pacer Advisors
Pennsylvania
– -$77K -6,050 Closed
STA
247
Summit Trail Advisors
New York
– -$82K -5,820 Closed
II
248
Inspire Investing
Idaho
– -$67K -5,212 Closed
CL
249
CSS LLC
Illinois
– -$81.1K -5,064 Closed
TRCT
250
Tower Research Capital (TRC)
New York
– -$60K -4,658 Closed
7 8 9
10
11

ARRY Hedge Fund Activity: Q1 2018 in Review

235 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2018, worth a combined $3.22B — up 26% from $2.56B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new ARRY positions and 20 closed out — a net gain of 46 holders — while 83 added to existing stakes and 62 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $49.6M. The largest seller was Point72 Asset Management, cutting an estimated $84.3M.

  • 235 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2018, up from 191 in Q4 2017.
  • Funds reported $3.22B of Array Biopharma Inc stock for Q1 2018, up 26% quarter-over-quarter.
  • 66 funds opened new Array Biopharma Inc positions in Q1 2018 and 20 closed out, a net change of +46 holders.
  • The largest Array Biopharma Inc buyer in Q1 2018 was Farallon Capital Management, an estimated $49.6M added.
  • The largest Array Biopharma Inc seller in Q1 2018 was Point72 Asset Management, an estimated $84.3M sold.

Based on aggregated 13F filings for Q1 2018.